Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology

References

• Al Fadel, F., et al., 2016. Involvement of sphingosine 1-phosphate in palmitate-induced non-alcoholic fatty liver disease. Cell cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 40, 1637–1645.
   PubMed Web of Science ®Google Scholar
• Alvarez, S.E., et al., 2010. Sphingosine-1-phosphate is a missing cofactor for the e3 ubiquitin ligase TRAF2. Nature, 465, 1084–1088.
   PubMed Web of Science ®Google Scholar
• Aoki, S., et al., 2005. Sphingosine 1-phosphate-related metabolism in the blood vessel. Journal of biochemistry, 138, 47–55.
   PubMed Web of Science ®Google Scholar
• Bataller, R. and Brenner, D.A. 2005. Liver fibrosis. Journal of clinical investigation, 115, 209–218.
   PubMed Web of Science ®Google Scholar
• Beltran-Sanchez, H., et al., 2013. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. Journal of the American College of Cardiology, 62, 697–703.
   PubMed Web of Science ®Google Scholar
• Bode, C., et al., 2010. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. Journal of cellular biochemistry, 109, 1232–1243.
   PubMed Web of Science ®Google Scholar
• Brice, S.E. and Cowart, L.A. 2011. Sphingolipid metabolism and analysis in metabolic disease. Advances in experimental medicine and biology, 721, 1–17.
   PubMed Web of Science ®Google Scholar
• Brinkmann, V., et al., 2010. Fingolimod (fty720): discovery and development of an oral drug to treat multiple sclerosis. Nature reviews drug discovery, 9, 883–897.
   PubMed Web of Science ®Google Scholar
• Cantrell Stanford, J., et al., 2012. Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells. The journal of biological chemistry, 287, 13457–13464.
   PubMed Web of Science ®Google Scholar
• Chang, N., et al., 2017. Hur mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis. Journal of molecular medicine, 95, 69–82.
   PubMed Web of Science ®Google Scholar
• Chavez, J.A. and Summers, S.A. 2012. A ceramide-centric view of insulin resistance. Cell metabolism, 15, 585–594.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2016a. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: role of PPARγ. Biochimica et biophysica acta, 1861, 138–147.
   PubMed Web of Science ®Google Scholar
• Chen, W., et al., 2016b. Sphingosine 1-phosphate in metabolic syndrome (review). International journal of molecular medicine, 38, 1030–1038.
   PubMed Web of Science ®Google Scholar
• Christensen, P.M., et al., 2016. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 30, 2351–2359.
   PubMed Web of Science ®Google Scholar
• Christoffersen, C., et al., 2011. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein m. Proceedings of the National Academy of Sciences of the United States of America, 108, 9613–9618.
   PubMed Web of Science ®Google Scholar
• Cohen, J.A. and Chun, J. 2011. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Annals of neurology, 69, 759–777.
   PubMed Web of Science ®Google Scholar
• Crespo, I., et al., 2016. Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin. Journal of pineal research, 61, 168–176.
   PubMed Web of Science ®Google Scholar
• Davaille, J., et al., 2000. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. The journal of biological chemistry, 275, 34628–34633.
   PubMed Web of Science ®Google Scholar
• Davaille, J., et al., 2002. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. The journal of biological chemistry, 277, 37323–37330.
   PubMed Web of Science ®Google Scholar
• Ding, B.S., et al., 2016. HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver. JCI insight, 1, e87058.
   PubMed Web of Science ®Google Scholar
• Fayyaz, S., et al., 2014. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia, 57, 373–382.
   PubMed Web of Science ®Google Scholar
• Feingold, K.R., et al., 2008. Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis, 199, 19–26.
   PubMed Web of Science ®Google Scholar
• Fox, T.E., et al., 2011. Circulating sphingolipid biomarkers in models of type 1 diabetes. Journal of lipid research, 52, 509–517.
   PubMed Web of Science ®Google Scholar
• Frej, C., et al., 2015. Quantification of sphingosine 1-phosphate by validated LC–MS/MS method revealing strong correlation with apolipoprotein m in plasma but not in serum due to platelet activation during blood coagulation. Analytical and bioanalytical chemistry, 407, 8533–8542.
   PubMed Web of Science ®Google Scholar
• Galvani, S., et al., 2015. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Science signalling, 8, ra79.
   PubMed Web of Science ®Google Scholar
• Geng, T., et al., 2015. SPHK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes. Journal of lipid research, 56, 2359–2371.
   PubMed Web of Science ®Google Scholar
• Grammatikos, G., et al., 2015. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection. Hepatology, 61, 812–822.
   PubMed Web of Science ®Google Scholar
• Hait, N.C., et al., 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science, 325, 1254–1257.
   PubMed Web of Science ®Google Scholar
• Hanel, P., et al., 2007. Erythrocytes store and release sphingosine 1-phosphate in blood. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 21, 1202–1209.
   PubMed Web of Science ®Google Scholar
• Hannun, Y.A. and Obeid, L.M. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature reviews molecular cell biology, 9, 139–150.
   PubMed Web of Science ®Google Scholar
• Holland, W.L., et al., 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature medicine, 17, 55–63.
   PubMed Web of Science ®Google Scholar
• Holland, W.L., et al., 2013. An fgf21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell metabolism, 17, 790–797.
   PubMed Web of Science ®Google Scholar
• Ikeda, H., et al., 2009. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. Journal of lipid research, 50, 556–564.
   PubMed Web of Science ®Google Scholar
• Ikeda, H., et al., 2010. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clinica chimica acta; international journal of clinical chemistry, 411, 765–770.
   PubMed Web of Science ®Google Scholar
• Jeong, J.K., et al., 2015. Modulation of the expression of sphingosine 1-phosphate 2 receptors regulates the differentiation of pre-adipocytes. Molecular medicine reports, 12, 7496–7502.
   PubMed Web of Science ®Google Scholar
• Jonnalagadda, D., et al., 2014. Granule-mediated release of sphingosine-1-phosphate by activated platelets. Biochimica et biophysica acta, 1841, 1581–1589.
   PubMed Web of Science ®Google Scholar
• Kaneko, T., et al., 2006. Sphingosine-1-phosphate receptor agonists suppress concanavalin a-induced hepatic injury in mice. Biochemical and biophysical research communications, 345, 85–92.
   PubMed Web of Science ®Google Scholar
• Kowalski, G.M., et al., 2013. Plasma sphingosine-1-phosphate is elevated in obesity. PLoS one, 8, e72449.
   PubMed Web of Science ®Google Scholar
• Kowalski, G.M., et al., 2015. Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet. Biochimica et biophysica acta, 1851, 210–219.
   PubMed Web of Science ®Google Scholar
• Kumaraswamy, S.B., et al., 2012. Decreased plasma concentrations of apolipoprotein m in sepsis and systemic inflammatory response syndromes. Critical care, 16, R60.
   PubMed Web of Science ®Google Scholar
• Kurano, M., et al., 2013. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis, 229, 102–109.
   PubMed Web of Science ®Google Scholar
• Kurano, M., et al., 2015. LDL receptor and apoE are involved in the clearance of apoM-associated sphingosine 1-phosphate. The journal of biological chemistry, 290, 2477–2488.
   PubMed Web of Science ®Google Scholar
• Kurek, K., et al., 2014. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver international: official journal of the liver, 34, 1074–1083.
   PubMed Web of Science ®Google Scholar
• Lee, S.Y., et al., 2015. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. Hepatology, 62, 135–146.
   PubMed Web of Science ®Google Scholar
• Lei, Y.C., et al., 2015a. Sphingosine kinase 1 dependent protein kinase c-delta activation plays an important role in acute liver failure in mice. World journal of gastroenterology, 21, 13438–13446.
   PubMed Web of Science ®Google Scholar
• Lei, Y.C., et al., 2015b. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. World journal of gastroenterology, 21, 13055–13063.
   PubMed Web of Science ®Google Scholar
• Lei, Y.C., et al., 2016. C5a/c5aR pathway is essential for up-regulating SPHK1 expression through p38-mapk activation in acute liver failure. World journal of gastroenterology, 22, 10148–10157.
   PubMed Web of Science ®Google Scholar
• Li, C., et al., 2009. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. Journal of hepatology, 50, 1174–1183.
   PubMed Web of Science ®Google Scholar
• Li, C., et al., 2011. Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. Journal of hepatology, 54, 1205–1213.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2013. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. The journal of pathology, 230, 365–376.
   PubMed Web of Science ®Google Scholar
• Liu, M., et al., 2014. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. The journal of biological chemistry, 289, 2801–2814.
   PubMed Web of Science ®Google Scholar
• Liu, M., et al., 2015. Uncleaved apoM signal peptide is required for formation of large apoM/sphingosine 1-phosphate (S1P)-enriched HDL particles. The journal of biological chemistry, 290, 7861–7870.
   PubMed Web of Science ®Google Scholar
• Lu, Z.P., et al., 2015. Hepatitis B virus x protein promotes human hepatoma cell growth via upregulation of transcription factor ap2alpha and sphingosine kinase 1. Acta pharmacologica sinica, 36, 1228–1236.
   PubMed Web of Science ®Google Scholar
• Ma, M.M., et al., 2007. Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in kk/ay diabetic mice. Diabetologia, 50, 891–900.
   PubMed Web of Science ®Google Scholar
• Maceyka, M., et al., 2012. Sphingosine-1-phosphate signaling and its role in disease. Trends in cell biology, 22, 50–60.
   PubMed Web of Science ®Google Scholar
• Maceyka, M. and Spiegel, S. 2014. Sphingolipid metabolites in inflammatory disease. Nature, 510, 58–67.
   PubMed Web of Science ®Google Scholar
• Mauer, A.S., et al., 2017. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. American journal of physiology. Gastrointestinal and liver physiology, 312, G300–G313.
   PubMed Web of Science ®Google Scholar
• Michels, M., et al., 2015. Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage. The journal of infection, 71, 480–487.
   PubMed Web of Science ®Google Scholar
• Moon, M.H., et al., 2014. Sphingosine-1-phosphate inhibits the adipogenic differentiation of 3t3-l1 preadipocytes. International journal of molecular medicine, 34, 1153–1158.
   PubMed Web of Science ®Google Scholar
• Nagahashi, M., et al., 2015. Conjugated bile acid activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology, 61, 1216–1226.
   PubMed Web of Science ®Google Scholar
• Nishi, T., et al., 2014. Molecular and physiological functions of sphingosine 1-phosphate transporters. Biochimica et biophysica acta, 841, 759–765.
   Web of Science ®Google Scholar
• Nowatari, T., et al., 2015. Sphingosine 1-phosphate has anti-apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human. Hepatology research: the official journal of the Japan Society of Hepatology, 45, 1136–1145.
   PubMed Web of Science ®Google Scholar
• Orr Gandy, K.A. and Obeid, L.M. 2013. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochimica et biophysica acta, 1831, 157–166.
   PubMed Web of Science ®Google Scholar
• Osawa, Y., et al., 2005. Roles for c16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. The journal of biological chemistry, 280, 27879–27887.
   PubMed Web of Science ®Google Scholar
• Osawa, Y., et al., 2011. Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through Akt activation and amp-activated protein kinase suppression. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 25, 1133–1144.
   PubMed Web of Science ®Google Scholar
• Pagadala, M., et al., 2012. Role of ceramides in nonalcoholic fatty liver disease. Trends in endocrinology and metabolism: TEM, 23, 365–371.
   PubMed Web of Science ®Google Scholar
• Pappu, R., et al., 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science, 316, 295–298.
   PubMed Web of Science ®Google Scholar
• Park, S.W., et al., 2010. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock, 33, 31–42.
   PubMed Web of Science ®Google Scholar
• Pellicoro, A., et al., 2014. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature reviews. Immunology, 14, 181–194.
   PubMed Web of Science ®Google Scholar
• Perz, J.F., et al., 2006. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology, 45, 529–538.
   PubMed Web of Science ®Google Scholar
• Pyne, N.J. and Pyne, S. 2010. Sphingosine 1-phosphate and cancer. Nature reviews. Cancer, 10, 489–503.
   PubMed Web of Science ®Google Scholar
• Qi, Y., et al., 2015. Sphingosine kinase 1 protects hepatocytes from lipotoxicity via down-regulation of IRE1α protein expression. The journal of biological chemistry, 290, 23282–23290.
   PubMed Web of Science ®Google Scholar
• Rehermann, B. and Nascimbeni, M. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nature reviews. Immunology, 5, 215–229.
   PubMed Web of Science ®Google Scholar
• Rosenberg, A.J., et al., 2016. Design, synthesis, and in vitro and in vivo evaluation of an (18)f-labeled sphingosine 1-phosphate receptor 1 (S1P1) pet tracer. Journal of medicinal chemistry, 59, 6201–6220.
   PubMed Web of Science ®Google Scholar
• Ross, J.S., et al., 2013. Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor alpha in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity. The journal of biological chemistry, 288, 22193–22206.
   PubMed Web of Science ®Google Scholar
• Ruiz, M., et al., 2017. High-density lipoprotein-associated apolipoprotein M limits endothelial inflammation by delivering sphingosine-1-phosphate to the sphingosine-1-phosphate receptor 1. Arteriosclerosis, thrombosis, and vascular biology, 37, 118–129.
   PubMed Web of Science ®Google Scholar
• Sakamoto, H., et al., 2005. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nature chemical biology, 1, 333–337.
   PubMed Web of Science ®Google Scholar
• Saltiel, A.R. and Kahn, C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414, 799–806.
   PubMed Web of Science ®Google Scholar
• Sanyal, A.J. and Pacana, T. 2015. A lipidomic readout of disease progression in a diet-induced mouse model of nonalcoholic fatty liver disease. Transactions of the American Clinical and Climatological Association, 126, 271–288.
   PubMedGoogle Scholar
• Satapathy, S.K. and Sanyal, A.J. 2015. Epidemiology and natural history of nonalcoholic fatty liver disease. Seminars in liver disease, 35, 221–235.
   PubMed Web of Science ®Google Scholar
• Sato, M., et al., 2016. Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human. Scientific reports, 6, 32119.
   PubMed Web of Science ®Google Scholar
• Schneider-Schaulies, J. and Schneider-Schaulies, S. 2015. Sphingolipids in viral infection. Biological chemistry, 396, 585–595.
   PubMed Web of Science ®Google Scholar
• Shi, Y., et al., 2012. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. Journal of hepatology, 56, 137–145.
   PubMed Web of Science ®Google Scholar
• Takabe, K. and Spiegel, S. 2014. Export of sphingosine-1-phosphate and cancer progression. Journal of lipid research, 9, 1839–1846.
   Web of Science ®Google Scholar
• Tian, T., et al., 2016. Sphingosine kinase 1 inhibition improves lipopolysaccharide/d-galactosamine-induced acute liver failure by inhibiting mitogen-activated protein kinases pathway. United European gastroenterology journal, 4, 677–685.
   PubMed Web of Science ®Google Scholar
• Umehara, T., et al., 2006. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Biochemical and biophysical research communications, 346, 67–73.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2013. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Biochemical pharmacology, 86, 1791–1804.
   PubMed Web of Science ®Google Scholar
• Wang, R., et al., 2015. Exosome adherence and internalization by hepatic stellate cells triggers sphingosine 1-phosphate-dependent migration. Journal of biological chemistry, 290, 30684–30696.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2017. The role of S1PR2 in bile acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Hepatology, 65, 2005–2018.
   PubMed Web of Science ®Google Scholar
• Watt, M.J., et al., 2012. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide. Diabetologia, 55, 2741–2746.
   PubMed Web of Science ®Google Scholar
• Xiu, L., et al., 2015. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors. The American journal of pathology, 185, 387–398.
   PubMed Web of Science ®Google Scholar
• Yamane, D., et al., 2014. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nature medicine, 20, 927–935.
   PubMed Web of Science ®Google Scholar
• Yanagida, K. and Hla, T. 2017. Vascular and immunobiology of the circulatory sphingosine 1-phosphate gradient. Annual review of physiology, 79, 67–91.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2013. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. Journal of hepatology, 59, 114–123.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2015. Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice. Scientific reports, 5, 13423.
   PubMed Web of Science ®Google Scholar
• Yatomi, Y. 2008. Plasma sphingosine 1-phosphate metabolism and analysis. Biochimica et biophysica acta, 1780, 606–611.
   PubMed Web of Science ®Google Scholar
• Yatomi, Y., et al., 1997. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. The Journal of biological chemistry, 272, 5291–5297.
   PubMed Web of Science ®Google Scholar
• Zhang, H., et al., 2016. Binding characteristics of sphingosine-1-phosphate to apoM hints to assisted release mechanism via the apoM calyx-opening. Scientific reports, 6, 30655.
   PubMed Web of Science ®Google Scholar